Scipher Medicine
  • Contact
  • Platform
  • Solutions
  • Company
  • Latest
  • Careers
  • Contact
  • Join Us

All articles

    All articles Press Releases Publications News Articles Media Kit
    Show all Press Releases Publications News Articles Media Kit
  • PrismRA test box 12/6/21
    Press releases
    Nearly 15% of Prescribing U.S. Rheumatologists Use Scipher Medicine’s PrismRA Blood Test Since Its Launch A Year Ago
  • Michael Elliott 12/2/21
    Press releases
    Scipher Medicine  Appoints Dr. Michael Elliott to its Science Advisory Board
  • Human Interactome Network 12/1/21
    Publications
    Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility
  • PrismRA test box 11/30/21
    Press releases, News articles
    America’s Choice Provider Network Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care
  • Sam Asgarian 11/16/21
    Press releases
    Scipher Medicine® Appoints Sam Asgarian, M.D., MBA, Chief Medical Officer
  • RxParadigm logo 11/15/21
    News articles
    RxParadigm Partners with Scipher Medicine® to Support Medication Utilization, Improve Patient Outcomes, and Lower Costs for Rheumatoid Arthritis Care
  • scipher medicine slash on purple background 11/11/21
    News articles
    Scipher Medicine® to Present at the Jeffries London Healthcare Conference
  • Interactome 11/10/21
    Publications
    A molecular signature response classifier to predict inadequate response to tumor necrosis factor-α Inhibitors: the NETWORK-004 Prospective Observational Study
  • scipher medicine slash on purple background 11/10/21
    News articles
    Scipher Medicine® to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
  • Human Disease 11/8/21
    Publications
    Discontinuation of TNFi treatment among Rheumatoid Arthritis patients with a molecular signature of non-response to tumor necrosis factor-ɑ inhibitor therapies
  • Blood Test 11/8/21
    Publications
    A molecular signature response classifier predicts the likelihood of non-response to TNF inhibitor therapies in RA at 3 months
  • GNS Healthcare logo 11/4/21
    Press releases
    GNS Healthcare and Scipher Medicine® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis
  • Tara logo 11/3/21
    News articles
    TARA Biosystems Partners with Scipher Medicine®
  • Disease Module Detection 10/26/21
    Publications
    Analytical and clinical validation of an RNA sequencing-based assay for quantitative, accurate evaluation of a molecular signature response classifier in rheumatoid arthritis
  • Trellis Rx logo 10/12/21
    Press releases
    Trellis Rx Furthers Commitment to Advancing the Specialty Pharmacy Practice and Patient Outcomes with Integration of Scipher Medicine® PrismRA® Precision-Medicine Technology into Clinical Pathways

Posts navigation

Previous 1 2 3 … 8 Next
Scipher Medicine
  • Privacy Policy
  • Patient Opt-out Information
  • Notice of Privacy Practices
  • Terms of Use
  • Cookies Acknowledgement
  • Site Map
©2023 Scipher Medicine. All rights reserved.
    • Platform
    • Solutions
    • Company
    • Latest
    • Careers
    • Contact
    • Join Us